News

Sofgen Pharmaceuticals, part of Procaps Group, is a leading provider of Contract Development and Manufacturing services in Softgel advanced technologies for generic, big pharmaceutical and nutraceutical companies in high regulated markets, will be exhibiting one more year at CPhI North America 2022.

As a leading pharmaceutical group, Procaps is focused on the expansion of its iCDMO business, offering integrated, end-to-end solutions in innovative dosage forms from development across delivery to the pharmaceutical and nutraceutical industries.

Creating revolutionary technologies for the Pharmaceutical Industry